Total Payments
$749.27
2024 Payments
$57.78
Companies
11
Transactions
16
Medicare Patients
720
Medicare Billing
$94,318
Payment Breakdown by Category
Food & Beverage$655.27 (87.5%)
Education$94.00 (12.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $655.27 | 15 | 87.5% |
| Education | $94.00 | 1 | 12.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $146.48 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $145.49 | 2 | $0 (2024) |
| Boston Scientific Corporation | $119.05 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $100.62 | 2 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $74.40 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $44.12 | 2 | $0 (2017) |
| Mayne Pharma Inc. | $43.31 | 2 | $0 (2017) |
| Wilson Cook Medical Incorporated | $32.91 | 1 | $0 (2017) |
| Foundation Medicine, Inc. | $15.05 | 1 | $0 (2019) |
| Shionogi Inc | $14.97 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.78 | 1 | Gilead Sciences, Inc. ($57.78) |
| 2022 | $118.53 | 1 | ABBVIE INC. ($118.53) |
| 2020 | $27.95 | 1 | AbbVie Inc. ($27.95) |
| 2019 | $236.78 | 4 | Boston Scientific Corporation ($119.05) |
| 2017 | $308.23 | 9 | Janssen Biotech, Inc. ($100.62) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $57.78 | General |
| Category: INFLAM | ||||||
| 03/16/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $118.53 | General |
| Category: VIROLOGY | ||||||
| 08/05/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: VIROLOGY | ||||||
| 07/15/2019 | Boston Scientific Corporation | GENERAL BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $119.05 | General |
| Category: BILIARY DEVICES | ||||||
| 05/31/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 05/18/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $87.71 | General |
| 04/16/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2017 | Janssen Biotech, Inc. | REMICADE (Biological) | Education | In-kind items and services | $94.00 | General |
| Category: Immunology | ||||||
| 05/05/2017 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: DERMATOLOGY | ||||||
| 04/22/2017 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: DERMATOLOGY | ||||||
| 04/11/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/10/2017 | Wilson Cook Medical Incorporated | Cook Medical Hemostasis (Device) | Food and Beverage | Cash or cash equivalent | $32.91 | General |
| Category: Endoscopy | ||||||
| 03/30/2017 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI, REMICADE | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Immunology | ||||||
| 03/27/2017 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $74.40 | General |
| Category: Immunology | ||||||
| 03/22/2017 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/22/2017 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 214 | 284 | $124,040 | $26,760 |
| 2022 | 4 | 81 | 121 | $52,560 | $13,209 |
| 2021 | 9 | 175 | 244 | $135,305 | $28,382 |
| 2020 | 11 | 250 | 300 | $159,045 | $25,966 |
Total Patients
720
Total Services
949
Medicare Billing
$94,318
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $16,920 | $5,123 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 34 | $18,190 | $3,832 | 21.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 37 | $9,250 | $3,689 | 39.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 54 | $9,180 | $3,529 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 36 | $14,400 | $2,859 | 19.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 24 | 29 | $5,220 | $1,981 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $11,400 | $1,950 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,800 | $1,450 | 18.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $15,960 | $1,385 | 8.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $15,720 | $962.08 | 6.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 59 | $15,960 | $5,040 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 34 | $14,450 | $4,521 | 31.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,660 | $2,303 | 30.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 14 | $14,490 | $1,345 | 9.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 40 | 79 | $33,575 | $11,403 | 34.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 29 | 29 | $47,850 | $6,259 | 13.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $8,850 | $2,518 | 28.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 22 | $6,710 | $1,905 | 28.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 30 | $6,450 | $1,808 | 28.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 16 | $17,280 | $1,764 | 10.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 17 | $5,440 | $1,354 | 24.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $4,400 | $1,254 | 28.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 23 | 25 | $4,750 | $118.07 | 2.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 42 | $17,850 | $4,866 | 27.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 23 | 23 | $37,950 | $4,787 | 12.6% |
About Dr. Michael Lin, M.D
Dr. Michael Lin, M.D is a Hepatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1063705309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lin, M.D has received a total of $749.27 in payments from pharmaceutical and medical device companies, with $57.78 received in 2024. These payments were reported across 16 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($655.27).
As a Medicare-enrolled provider, Lin has provided services to 720 Medicare beneficiaries, totaling 949 services with total Medicare billing of $94,318. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Hepatology
- Other Specialties Transplant Hepatology
- Location Los Angeles, CA
- Active Since 05/19/2011
- Last Updated 08/19/2022
- Taxonomy Code 207RI0008X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063705309
Products in Payments
- MAVYRET (Drug) $146.48
- GENERAL BILIARY DEVICES (Device) $119.05
- REMICADE (Biological) $94.00
- STELARA (Biological) $81.02
- Livdelzi (Drug) $57.78
- BREATHTEK (Device) $44.12
- DORYX (Drug) $43.31
- Cook Medical Hemostasis (Device) $32.91
- FOUNDATIONONE (Device) $15.05
- Mulpleta (Drug) $14.97
- GATTEX (Drug) $12.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hepatology Doctors in Los Angeles
Mr. Sergio Rojter, M.d, M.D
Hepatology — Payments: $94,597
Hepatology $94,597
Valerie Shin
Hepatology — Payments: $5,080
Hepatology $5,080
Amandeep Sahota, Md, MD
Hepatology — Payments: $135.62
Hepatology $135.62
Victor Wu, Md, MD
Hepatology — Payments: $19.46
Hepatology $19.46
Karl Esrason, Md, MD
Hepatology
Hepatology
Kwang Tung, Md, MD
Hepatology
Hepatology